22nd Century Group (XXII) Stock Price, News & Analysis $0.23 -0.01 (-4.13%) (As of 12/8/2023 08:58 PM ET) Add Compare Share Share Today's Range$0.21▼$0.2350-Day Range$0.21▼$0.8852-Week Range$0.20▼$18.98Volume1.06 million shsAverage Volume688,991 shsMarket Capitalization$7.10 millionP/E RatioN/ADividend YieldN/APrice Target$19.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 22nd Century Group MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside8,233.3% Upside$19.17 Price TargetShort InterestHealthy4.90% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($4.30) to ($0.95) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.28 out of 5 stars 3.3 Analyst's Opinion Consensus Rating22nd Century Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $19.17, 22nd Century Group has a forecasted upside of 8,233.3% from its current price of $0.23.Amount of Analyst Coverage22nd Century Group has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted4.90% of the float of 22nd Century Group has been sold short.Short Interest Ratio / Days to Cover22nd Century Group has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in 22nd Century Group has recently decreased by 19.46%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend Yield22nd Century Group does not currently pay a dividend.Dividend Growth22nd Century Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for XXII. Previous Next 3.3 News and Social Media Coverage News Sentiment22nd Century Group has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 3 news articles for 22nd Century Group this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for XXII on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows7 people have added 22nd Century Group to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 22nd Century Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.60% of the stock of 22nd Century Group is held by insiders. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for 22nd Century Group are expected to grow in the coming year, from ($4.30) to ($0.95) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 22nd Century Group is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 22nd Century Group is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio22nd Century Group has a P/B Ratio of 0.03. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About 22nd Century Group Stock (NASDAQ:XXII)22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.Read More XXII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XXII Stock News HeadlinesDecember 11, 2023 | americanbankingnews.com22nd Century Group (NASDAQ:XXII) vs. Japan Tobacco (OTCMKTS:JAPAF) Head-To-Head AnalysisDecember 7, 2023 | markets.businessinsider.comOptimistic Outlook: Buy Rating on 22nd Century Group Amidst Leadership Change and Strategic ShiftDecember 11, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comDecember 4, 2023 | finance.yahoo.com22nd Century Secures $3.2 Million to Date in Warrant Exchange TransactionDecember 1, 2023 | americanbankingnews.com22nd Century Group, Inc. (NASDAQ:XXII) Short Interest UpdateNovember 29, 2023 | finanznachrichten.de22nd Century Group, Inc: 22nd Century Appoints Larry Firestone as Chairman and CEONovember 29, 2023 | markets.businessinsider.com22nd Century Appoints Larry Firestone As Chairman, CEONovember 29, 2023 | finance.yahoo.com22nd Century Appoints Larry Firestone as Chairman and CEODecember 11, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 28, 2023 | msn.com22nd Century Group Offloads Hemp/Cannabis Franchise In $2.25M Deal, Seeks To 'Reduce Cash And Operating Demands'November 28, 2023 | finanznachrichten.de22nd Century Group, Inc: 22nd Century Group Enters into Agreement to Sell Hemp/Cannabis FranchiseNovember 27, 2023 | msn.com22nd Century to sell its hemp/cannabis franchise, stock jumps ~13% after hoursNovember 27, 2023 | msn.com22nd Century Group (XXII) Price Target Increased by 30.94% to 41.93November 27, 2023 | finance.yahoo.com22nd Century Group Enters into Agreement to Sell Hemp/Cannabis FranchiseNovember 24, 2023 | realmoney.thestreet.comThis Stock Is Not Having Its Moment of the 'Century'November 24, 2023 | finance.yahoo.comThese Analysts Just Made A Substantial Downgrade To Their 22nd Century Group, Inc. (NASDAQ:XXII) EPS ForecastsNovember 21, 2023 | marketwatch.com22nd Century Group's Stock Slides After Analyst Pulls Price TargetNovember 8, 2023 | finance.yahoo.com22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 StoresNovember 7, 2023 | finance.yahoo.com22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology LicenseNovember 6, 2023 | bizjournals.com22nd Century loses $73M in 3rd quarterNovember 6, 2023 | finance.yahoo.com22nd Century Group (XXII) Reports Third Quarter 2023 Financial ResultsNovember 6, 2023 | finance.yahoo.com22nd Century Group Inc (XXII) Reports Q3 2023 Financial Results: Net Loss Widens Amid Expansion ...October 26, 2023 | finance.yahoo.com22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMBOctober 25, 2023 | finance.yahoo.com22nd Century Group (XXII) Reduces Debt by $8.1 MillionOctober 17, 2023 | marketwatch.com22nd Century Group Shares Fall 13% After Share Sale PricedOctober 17, 2023 | msn.com22nd Century Group prices public offering to raise $5.25MOctober 17, 2023 | finance.yahoo.com22nd Century Announces Pricing of $5.25 Million Public OfferingSee More Headlines Receive XXII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/06/2023Today12/11/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Cigarettes Sub-IndustryCannabis SectorConsumer Staples Current SymbolNASDAQ:XXII Previous SymbolAMEX:XXII CUSIPN/A CIK1347858 Webwww.xxiicentury.com Phone(716) 270-1523Fax716-877-3064Employees198Year FoundedN/APrice Target and Rating Average Stock Price Target$19.17 High Stock Price Target$45.00 Low Stock Price Target$5.00 Potential Upside/Downside+8,233.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($8.0785) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-59,800,000.00 Net Margins-167.13% Pretax Margin-164.47% Return on Equity-121.41% Return on Assets-74.82% Debt Debt-to-Equity Ratio0.01 Current Ratio1.02 Quick Ratio0.62 Sales & Book Value Annual Sales$62.11 million Price / Sales0.11 Cash FlowN/A Price / Cash FlowN/A Book Value$6.68 per share Price / Book0.03Miscellaneous Outstanding Shares30,880,000Free Float30,693,000Market Cap$7.10 million OptionableOptionable Beta1.58 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. James A. Mish (Age 59)Corporate President, Member of Scientific Advisory Board & Director Comp: $985.11kMr. R. Hugh KinsmanChief Financial OfficerMr. John J. Miller (Age 58)COO & Executive Officer Comp: $596.38kMr. Lawrence D. Firestone (Age 65)Chairman & CEO Mr. Peter F. Ferola (Age 54)Chief Legal Officer & Corporate Secretary Mr. Sebastian RavitzVice President of MarketingMatthew KrepsInvestor RelationsMr. James C. MorrisonTechnical Advisor & Regulatory Affairs ConsultantMore ExecutivesKey CompetitorsEducational DevelopmentNASDAQ:EDUCSteakholder FoodsNASDAQ:STKHStryve FoodsNASDAQ:SNAXFarmmiNASDAQ:FAMIDAVIDsTEANASDAQ:DTEAView All CompetitorsInstitutional OwnershipWalleye Capital LLCBought 60,900 shares on 11/21/2023Ownership: 0.000%Mercer Global Advisors Inc. ADVBought 75,621 shares on 11/15/2023Ownership: 0.245%TRUE Private Wealth AdvisorsSold 80,635 shares on 11/13/2023Ownership: 0.096%HighTower Advisors LLCBought 78,458 shares on 11/8/2023Ownership: 0.372%Cutler Group LLC CABought 5,700 shares on 11/7/2023Ownership: 0.000%View All Institutional Transactions XXII Stock Analysis - Frequently Asked Questions Should I buy or sell 22nd Century Group stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" XXII shares. View XXII analyst ratings or view top-rated stocks. What is 22nd Century Group's stock price target for 2024? 4 Wall Street research analysts have issued 1 year target prices for 22nd Century Group's shares. Their XXII share price targets range from $5.00 to $45.00. On average, they anticipate the company's stock price to reach $19.17 in the next twelve months. This suggests a possible upside of 8,233.3% from the stock's current price. View analysts price targets for XXII or view top-rated stocks among Wall Street analysts. How have XXII shares performed in 2023? 22nd Century Group's stock was trading at $13.8075 at the start of the year. Since then, XXII shares have decreased by 98.3% and is now trading at $0.23. View the best growth stocks for 2023 here. Are investors shorting 22nd Century Group? 22nd Century Group saw a drop in short interest in November. As of November 15th, there was short interest totaling 1,490,000 shares, a drop of 19.5% from the October 31st total of 1,850,000 shares. Based on an average daily volume of 717,200 shares, the short-interest ratio is currently 2.1 days. Currently, 4.9% of the company's shares are short sold. View 22nd Century Group's Short Interest. When is 22nd Century Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024. View our XXII earnings forecast. How were 22nd Century Group's earnings last quarter? 22nd Century Group, Inc. (NASDAQ:XXII) posted its quarterly earnings data on Monday, November, 6th. The biotechnology company reported ($0.78) earnings per share for the quarter, topping the consensus estimate of ($0.91) by $0.13. The biotechnology company earned $17.81 million during the quarter, compared to analyst estimates of $20.06 million. 22nd Century Group had a negative net margin of 167.13% and a negative trailing twelve-month return on equity of 121.41%. What ETF holds 22nd Century Group's stock ? ETFMG Alternative Harvest ETF holds 55,201 shares of XXII stock, representing 0.08% of its portfolio. When did 22nd Century Group's stock split? 22nd Century Group's stock reverse split on the morning of Wednesday, July 5th 2023. The 1-15 reverse split was announced on Wednesday, July 5th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of 22nd Century Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Enphase Energy (ENPH), Inseego (INSG), Luckin Coffee (LKNCY), MediPharm Labs (MEDIF) and MercadoLibre (MELI). Who are 22nd Century Group's major shareholders? 22nd Century Group's stock is owned by many different retail and institutional investors. Top institutional investors include HighTower Advisors LLC (0.37%), Mercer Global Advisors Inc. ADV (0.24%), Walleye Capital LLC (0.00%), TRUE Private Wealth Advisors (0.10%), Cutler Group LLC CA (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clifford B Fleet, James A Mish, John Franzino, Michael Zercher and Roger D O'brien. View institutional ownership trends. How do I buy shares of 22nd Century Group? Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:XXII) was last updated on 12/11/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 22nd Century Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.